Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

44
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
44
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

45
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
45
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

28
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
28
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

31
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
31
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

24
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

45
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
45

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026
Same author

Persistent symptoms and healthcare utilisation during five-year follow-up after SARS-CoV-2 infection: A multicentre cohort study in Spain.

Journal of infection and public health·2026
Same author

Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Outcomes and factors associated with medical treatment failure in patients with spinal epidural abscess: A 14-year experience.

PloS one·2026
Same author

In vitro and in vivo activity of daptomycin plus ceftaroline for the treatment of experimental endocarditis due to Enterococcus faecalis with and without high-level aminoglycoside resistance.

The Journal of antimicrobial chemotherapy·2026
Same author

Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

Journal of the International AIDS Society·2026

Related Experiment Video

Updated: Sep 23, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.2K

Infective Endocarditis in Diabetic Patients: A Different Profile with Prognostic Consequences.

María Isabel Biezma1, Patricia Muñoz2,3, Sofía De la Villa2

  • 1Escuela de Doctorado, Universidad Europea de Madrid, 28670 Madrid, Spain.

Journal of Clinical Medicine
|May 14, 2022
PubMed
Summary

The prevalence of diabetes mellitus (DM) in infective endocarditis (IE) is rising. DM significantly increases mortality risk in IE patients, especially when organ damage is present.

Keywords:
diabetes mellitusin-hospital mortalityinfective endocarditisone-year mortalityorgan damageprognosis

More Related Videos

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.0K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

308

Related Experiment Videos

Last Updated: Sep 23, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.2K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.0K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

308

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Endocrinology

Background:

  • Infective endocarditis (IE) is a serious infection with significant morbidity and mortality.
  • Diabetes mellitus (DM) is a known risk factor for poor outcomes in various medical conditions.

Purpose of the Study:

  • To investigate the prevalence and prognosis of IE in patients with and without DM.
  • To analyze the impact of DM-related organ damage on IE outcomes.

Main Methods:

  • Retrospective analysis of the Spanish IE Registry from 2008 to 2020.
  • Inclusion of 5590 IE patients, comparing outcomes between those with and without DM.
  • Assessment of DM-related organ damage as a prognostic factor.

Main Results:

  • DM prevalence in IE patients increased to over 30% in the latter study period.
  • Patients with DM exhibited higher in-hospital (32.1% vs. 23.3%) and one-year mortality (39.4% vs. 28.5%) compared to non-DM patients.
  • DM-related organ damage was independently associated with increased in-hospital (OR=1.37) and one-year mortality (OR=1.59) in IE patients.

Conclusions:

  • The rising prevalence of DM in IE necessitates attention to this comorbidity.
  • DM is an independent predictor of poor prognosis in IE.
  • DM-related organ damage further exacerbates mortality risk in IE patients, highlighting the need for targeted management.